University of Alberta

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1908-01-01

Employees: 10K

Market Cap: -

Website: http://www.ualberta.ca

Clinical Trials

18F-PSMA-1007 PET/CT Imaging in Patients With Biochemically Recurrent or High-risk Prostate Cancer

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Diagnostic Test: 18F-PSMA-1007

First Posted Date: 2021-02-02

Last Posted Date: 2023-11-27

Lead Sponsor: University of Alberta

Target Recruit Count: 100

Registration Number: NCT04733768

Locations: 🇨🇦
University of Alberta, Edmonton, Alberta, Canada

Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19

Completed

Conditions: Covid19
Dyspnea

Interventions: Other: No Intervention

First Posted Date: 2021-02-01

Last Posted Date: 2024-05-08

Lead Sponsor: University of Alberta

Target Recruit Count: 64

Registration Number: NCT04732663

Locations: 🇨🇦
Clinical Physiology Laboratory, Edmonton, Alberta, Canada

Biomarkers of Mortality and Morbidity in Children Hospitalized With Fever

Completed

Conditions: Fever

First Posted Date: 2021-01-27

Last Posted Date: 2021-01-27

Lead Sponsor: University of Alberta

Target Recruit Count: 2500

Registration Number: NCT04726826

Locations: 🇺🇬
Jinja Regional Referral Hospital, Jinja, Uganda

Laparoscopically Guided Rectus Sheath Block in Pediatric Appendicitis

Phase 2

Completed

Conditions: Appendicitis Acute

First Posted Date: 2021-01-22

Last Posted Date: 2024-03-12

Lead Sponsor: University of Alberta

Target Recruit Count: 42

Registration Number: NCT04717193

Locations: 🇨🇦
Stollery Children's Hospital, Edmonton, Alberta, Canada

Trifecta-Heart cfDNA-MMDx Study

Recruiting

Conditions: Heart Transplant Rejection

Interventions: Diagnostic Test: MMDx diagnostic test
Diagnostic Test: Prospera
Diagnostic Test: HLA antibody

First Posted Date: 2021-01-13

Last Posted Date: 2025-06-06

Lead Sponsor: University of Alberta

Target Recruit Count: 300

Registration Number: NCT04707872

Locations: 🇺🇸
Baptist Health Institute for Research and Innovation, Little Rock, Arkansas, United States
🇺🇸
Columbia University Medical Center, Columbia Interventional Cardiovascular Care, W. New York, New Jersey, United States
🇺🇸
Montefiore Medical Center, 3319 Rochambeau Avenue, 2nd FL, Bronx, New York, United States

and more 8 locations

18F-DOPA II - PET Imaging Optimization

Phase 3

Recruiting

Conditions: Congenital Hyperinsulinism
Brain Tumor
Neuroblastoma
Neuroendocrine Tumors
Parkinson Disease
Lewy Body Disease

Interventions: Drug: 18F-DOPA
Drug: Furosemide Injection

First Posted Date: 2021-01-13

Last Posted Date: 2025-05-07

Lead Sponsor: University of Alberta

Target Recruit Count: 800

Registration Number: NCT04706910

Locations: 🇨🇦
WC Mackenzie Health Science Centre / University of Alberta Hospital, Edmonton, Alberta, Canada

Efficacy of Ketamine in Post Anesthesia Recovery Room

Completed

Conditions: Pain, Postoperative
Ketamine Adverse Reaction
Pain, Refractory
Pain, Acute
Pain, Intractable

Interventions: Drug: Ketamine

First Posted Date: 2021-01-08

Last Posted Date: 2022-07-28

Lead Sponsor: University of Alberta

Target Recruit Count: 143

Registration Number: NCT04701008

Locations: 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada

Swallowing Therapy With the Assistance of a Mobile Health Device in Head and Neck Cancer Patients: a Pan-Alberta Study

Not Applicable

Completed

Conditions: Dysphagia
Head and Neck Cancer

Interventions: Other: Swallowing exercise from home

First Posted Date: 2021-01-07

Last Posted Date: 2024-02-05

Lead Sponsor: University of Alberta

Target Recruit Count: 18

Registration Number: NCT04698499

Locations: 🇨🇦
University of Alberta, Edmonton, Alberta, Canada

Mindful Kangaroo Care: Mindfulness Intervention for Mothers During Skin-to-skin Care

Not Applicable

Completed

Conditions: Anxiety
Depression
Stress

Interventions: Behavioral: Mindfulness

First Posted Date: 2021-01-06

Last Posted Date: 2021-01-07

Lead Sponsor: University of Alberta

Target Recruit Count: 32

Registration Number: NCT04696770

Locations: 🇨🇦
Royal Alexandra Hospital, NICU, Edmonton, Alberta, Canada

Safety, Tolerability and Efficacy of Nefopam Cream in Burn Patients

Phase 2

Recruiting

Conditions: Burn; Multiple Body Regions, Max. Second Degree
Third-Degree Burn
Burn Degree Second

Interventions: Other: Placebo (Vehicle)
Drug: Nefopam

First Posted Date: 2020-12-28

Last Posted Date: 2025-01-22

Lead Sponsor: University of Alberta

Target Recruit Count: 60

Registration Number: NCT04685577

Locations: 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy